文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血管加压药拐点对脓毒性休克患者短期预后的评估价值

EVALUATION OF VASOPRESSOR INFLECTION POINT FOR SHORT-TERM PROGNOSIS OF PATIENTS WITH SEPTIC SHOCK.
PubMed 文献 · Shock · 2024-06-04
一句话结论单中心回顾性研究显示,血管加压药拐点预测脓毒性休克短期预后优于降钙素原拐点,第4天灵敏度100%、特异度86.4%。

该研究回顾性分析2021年1月至2023年3月重症医学科收治的56例脓毒性休克患者,按预后分为存活组34例和死亡组22例,以启动血管加压药治疗为起点,分别判定血管加压药拐点(剂量开始下降的时间)和降钙素原(PCT)拐点(PCT开始下降的时间)。比较两组在启动血管加压药后第2、3、4天达到拐点的发生率,采用Fisher精确检验、单因素logistic回归及四格表法评估诊断效能,并用配对卡方检验和Kappa一致性检验比较两种方法。结果显示血管加压药拐点第2、3、4天灵敏度分别为76.4%、88.2%、100%,特异度分别为90.9%、90.9%、86.4%,阳性预测值分别为92.9%、93.8%、91.9%,第2天阴性预测值为71.4%,约登指数分别为0.673、0.791、0.864,各相应时间点指标均超过PCT拐点。结论认为血管加压药拐点是脓毒性休克短期预后的有力工具,在预后评估方面优于PCT。

要点

  • 脓毒性休克患者血管加压药拐点第4天预测短期预后灵敏度100%、特异度86.4%、阳性预测值91.9%、约登指数0.864。
  • 第3天血管加压药拐点灵敏度88.2%、特异度90.9%、阳性预测值93.8%、约登指数0.791。
  • 第2天血管加压药拐点灵敏度76.4%、特异度90.9%、阳性预测值92.9%、阴性预测值71.4%、约登指数0.673。
  • 血管加压药拐点在上述各时间点的评估指标均超过PCT拐点。
  • 研究为单中心回顾性分析,共56例脓毒性休克患者,存活组34例、死亡组22例。

适用人群与场景

  • 2021年1月至2023年3月在医院重症医学科收治的56例脓毒性休克患者。
  • 按预后分为存活组34例和死亡组22例。

诊断标准与关键阈值

  • 血管加压药拐点:以启动血管加压药治疗为参照点,血管加压药剂量开始下降的时间。
  • PCT拐点:以启动血管加压药治疗为参照点,PCT水平开始下降的时间。

研究设计与关键结果

  • 研究类型为回顾性分析,共纳入56例脓毒性休克患者,存活组34例、死亡组22例。
  • 血管加压药拐点第2天灵敏度76.4%、特异度90.9%、阳性预测值92.9%、阴性预测值71.4%、约登指数0.673。
  • 血管加压药拐点第3天灵敏度88.2%、特异度90.9%、阳性预测值93.8%、约登指数0.791。
  • 血管加压药拐点第4天灵敏度100%、特异度86.4%、阳性预测值91.9%、约登指数0.864。
  • 血管加压药拐点在各相应时间点的全部指标均超过PCT拐点。
  • 两组拐点比较采用Fisher精确检验,预后评估采用单因素logistic回归,诊断效能采用四格表法,两种方法差异与一致性采用配对卡方检验和Kappa一致性检验。

证据类型、等级与局限

  • 证据类型:回顾性分析(单中心)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为血管加压药拐点是脓毒性休克患者短期预后的有力评估工具。
  • 作者认为血管加压药拐点在预后评估方面优于PCT拐点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: The goal of this study is to investigate the clinical value of vasopressor inflection points in the evaluation of short-term prognosis among individuals afflicted with septic shock. Methods: A retrospective analysis was conducted on a cohort comprising 56 patients diagnosed with septic shock and receiving treatment at the department of critical care medicine of the hospital between January 2021 and March 2023. These patients were divided into two groups based on the prognostic outcome: a survival group consisting of 34 patients and a death group consisting of 22 patients. The determination of vasopressor inflection time and procalcitonin (PCT) inflection time of each patient was undertaken with the initiation of vasopressor therapy serving as the reference point. The vasopressor inflection point was defined as the time when the dosage of vasopressors commenced decreasing, while the PCT inflection point denoted the time when PCT levels began to decline. The incidence of patients reaching the vasopressor and PCT inflection points on the 2nd, 3rd, and 4th days following the initiation of vasopressor therapy was tabulated for both groups. The comparison of inflection points between the two groups at each time point was conducted using Fisher's exact test. Furthermore, logistic regression analysis was employed for univariate prognostic assessment. The diagnostic performance of vasopressor and PCT inflection point was assessed using the four-table method. The discrepancy and consistency between the two methods were evaluated through paired chi-squared test and Kappa consistency test. Results: The vasopressor inflection point demonstrates promising utility in the assessment of short-term prognosis among patients with septic shock, exhibiting sensitivities of 76.4%, 88.2%, and 100%, specificities of 90.9%, 90.9%, and 86.4%, positive predictive values of 92.9%, 93.8%, and 91.9%, and negative predictive values of 71.4% on the 2nd, 3rd, and 4th day, respectively. Correspondingly, the Youden indices were calculated as 0.673, 0.791, and 0.864 on these respective days. Notably, all metrics at comparable intervals surpassed those of the PCT inflection point. Conclusion : The vasopressor inflection point presents as a robust prognostic tool for the short-term outcomes in patients with septic shock and exhibits superiority over PCT in prognostic assessment.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Yang M, Chen SG. EVALUATION OF VASOPRESSOR INFLECTION POINT FOR SHORT-TERM PROGNOSIS OF PATIENTS WITH SEPTIC SHOCK. Shock. 2024. PMID: 38888490. doi:10.1097/SHK.0000000000002415

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。